Text

BLOOD COMPONENTS AND PHARMACOLOGIC AGENTS IN THE TREATMENT OF CONGENITAL AND ACQUIRED BLEEDING DISORDERS

---

Evaluation of patients with abnormal screening studies;rnPoint of care coagulation instruments;rnLocalized bleeding; choosing a hemostatic agent;rnTreatment of patients who refuse blood components;rnThrombocytopenia in the critical care patient;rnOptions for the nonhemphilic patient with an inhibitor against factor VIII;rnRecognition and treatment of patients with coagulation factor inhibitor in the critical care setting;rnHemostatic defects in uremia;rnManagement of hemastotic disorders of liver disease;rnDisseminated intravascular coagulation;rnEvaluation and treatment of bleeding associated with heparin and low molecular weight heparin administration;rnTreatment of bleeding in patients receiving thrombolytic and/or antipalent agents;rnManagement of wafarin induced bleeding;rnManagement issues in thrombocytic thrombocytopenic purpura/hemolytic uremic syndrome;rnManagement issues in idiopathic thrombocytopenic purpura (ITP)

---

Ketersediaan

BLO

616.15 BAR b

My Library (Rak 01)

Tersedia

Informasi Detail

Judul Seri

-

No. Panggil

616.15 BAR b

Penerbit

Amerika : AABB Press., 2000

Deskripsi Fisik

xviii, 367 hal; ilus; 22,5 cm

Bahasa

Indonesia

ISBN/ISSN

1563951118

Klasifikasi

616.15 BAR b

Tipe Isi

-

Tipe Media

-

Tipe Pembawa

-

Edisi

-

Subjek

Darah

Info Detail Spesifik

-

Pernyataan Tanggungjawab

-

Versi lain/terkait

Lampiran Berkas

Komentar

---

Anda harus masuk sebelum memberikan komentar